3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Colorectal Neoplasms
30
Carcinoma, Hepatocellular
13
Rectal Neoplasms
5
Sarcoma, Ewing
4
Osteosarcoma
4
Gastrointestinal Stromal Tumors
4
Colonic Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
3
Glioblastoma
3
Sarcoma
2
Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Esophageal Neoplasms
2
Chondrosarcoma
2
Bone Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Solid Malignant Tumors
1
Small Cell Lung Carcinoma
1
Recurrence
1
Piebaldism
1
Patient Compliance
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
regorafenib
2
ivosidenib
2
Proton Therapy
2
enasidenib
1
durvalumab
1
capivasertib
1
abemaciclib
1
Zoledronic Acid
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Range of Motion, Articular
1
Pharmacogenomic Testing
1
Paclitaxel
1
Immunoglobulin G
1
HhAntag691
1
Gemcitabine
1
Disulfides
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
regorafenib
×
1 year
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled
NCT02389244
2025-09-16
REGOBONE
UNICANCER
Phase 2
Active not recruiting
163 enrolled